about
Advanced MRI and staging of multiple sclerosis lesionsPrimary progressive multiple sclerosis: tactile-associated functional MR activity in the cervical spinal cord.Functional and structural connectivity of the motor network in pediatric and adult-onset relapsing-remitting multiple sclerosis.Rapid semi-automatic segmentation of the spinal cord from magnetic resonance images: application in multiple sclerosis.Intrinsic damage to the major white matter tracts in patients with different clinical phenotypes of multiple sclerosis: a voxelwise diffusion-tensor MR study.The role of advanced magnetic resonance imaging techniques in primary progressive MS.Overcoming the clinical-MR imaging paradox of multiple sclerosis: MR imaging data assessed with a random forest approach.Postmortem magnetic resonance imaging to guide the pathologic cut: individualized, 3-dimensionally printed cutting boxes for fixed brainsPatients with migraine do not have MRI-visible cortical lesions.Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis.In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.Optimized T1-MPRAGE sequence for better visualization of spinal cord multiple sclerosis lesions at 3TInsights from magnetic resonance imaging.Direct MRI detection of impending plaque development in multiple sclerosis.Leptomeningeal gadolinium enhancement across the spectrum of chronic neuroinflammatory diseases.MRI predicts efficacy of constraint-induced movement therapy in children with brain injuryPersistent 7-tesla phase rim predicts poor outcome in new multiple sclerosis patient lesions.Utilizing 3D Printing Technology to Merge MRI with Histology: A Protocol for Brain Sectioning.Spring cleaning: time to rethink imaging research lines in MS?Clinical 3-tesla FLAIR* MRI improves diagnostic accuracy in multiple sclerosis.Human and nonhuman primate meninges harbor lymphatic vessels that can be visualized noninvasively by MRI.Fibrinogen Activates BMP Signaling in Oligodendrocyte Progenitor Cells and Inhibits Remyelination after Vascular Damage.Diagnostic performance of central vein sign for multiple sclerosis with a simplified three-lesion algorithm.Central vein sign differentiates Multiple Sclerosis from central nervous system inflammatory vasculopathies.Brain macro- and microscopic damage in patients with paediatric MS.Location of brain lesions predicts conversion of clinically isolated syndromes to multiple sclerosis.Regional cervical cord atrophy and disability in multiple sclerosis: a voxel-based analysis.Assessment of white matter tract damage in mild cognitive impairment and Alzheimer's disease.Cervical cord FMRI abnormalities differ between the progressive forms of multiple sclerosis.Sensorimotor network rewiring in mild cognitive impairment and Alzheimer's disease.Spatial normalization and regional assessment of cord atrophy: voxel-based analysis of cervical cord 3D T1-weighted images.Abnormal cervical cord function contributes to fatigue in multiple sclerosis.Slowly eroding lesions in multiple sclerosis.Selective decreased grey matter volume of the pain-matrix network in cluster headache.Tract-specific white matter structural disruption in patients with bipolar disorder.Intranetwork and internetwork functional connectivity abnormalities in pediatric multiple sclerosis.Spatiotemporal distribution of fibrinogen in marmoset and human inflammatory demyelination.A multicentre study of motor functional connectivity changes in patients with multiple sclerosisAbnormal connectivity of the sensorimotor network in patients with MS: A multicenter fMRI studyPosterior brain damage and cognitive impairment in pediatric multiple sclerosis
P50
Q30825494-0578A596-3B1D-400B-BA6B-4222F42672BAQ33496398-35CA0ECE-5C25-4EB7-987B-2C7065C789FBQ33525778-676A0039-DC2C-4292-B54B-5E8A45259A92Q33694036-2F5DBE6A-A35D-4B5D-9140-9170C865DA20Q33932577-925A33C5-EBC5-4937-9412-D98CFB1D1077Q33981654-0AE767BC-9EB1-45AB-87B7-FDB56DB81B93Q34073979-D65B14E5-B158-4F55-BD45-78C6A55CEC69Q34086940-12DFF119-D255-4D21-BA84-5849F6D8BED4Q34309543-0DBA2EB5-B050-499C-911D-5230E6DDF7CAQ34472457-C7A20E78-747A-4969-B3E1-FDDCE329CA50Q34632538-03E32906-9AB6-4292-B764-860E6AEF8623Q34781818-83A53387-59EC-41D1-8C3B-D8CEFDDB9607Q35089139-97E3ECDA-8DA7-47AB-8676-D1EFCDBDAAE1Q36031724-E19E5910-11E5-44A6-B51C-896023484C9FQ36304912-B1F6BF47-3E3B-4F8D-99F2-F9079F613EF4Q36983197-63943E32-6B28-4BE5-9F67-F03D55424BF9Q37042300-9BAA043A-3E3D-4843-A940-6DBCE3357B70Q37580028-F03DF191-0023-489A-8B5B-CF2AC01FFC0EQ38737202-A8971FF4-F93D-4E6C-8B54-454816890B22Q41654013-DC964687-5BC8-4CE1-8A0B-2BF57E2A08B0Q41843877-AE872B2A-8DEF-44E4-8961-8F87585DCFDDQ46448356-92356C08-A288-46CF-A8A7-E1C9E871360FQ47721240-57E01DAA-BF46-481E-804A-B7D8998B519BQ47867823-19FF7A90-E5B2-4622-B56A-BFB9A7581342Q48111458-86931A9D-9568-470E-B189-F2B8D7085C45Q48261199-92D91034-F359-4FA7-8E9A-F500C0E5AA7FQ48275470-026FB92D-94F2-4115-BC33-D6335232BF97Q48303832-EFEA8F7D-578B-48E0-AF0E-83B86F60B0D4Q48411314-28311AE2-8168-4A09-995C-EB7F3041BCF9Q48451289-35486AAF-FF03-4D49-BB8A-348CC5E38E5FQ48479692-B3751BDA-F315-44F8-ADB8-08F623767042Q48629230-5EB6D2D9-9953-49C8-AE7C-FD1E890F7718Q48658716-F177B55F-A325-4A44-8F85-6C17C2C9D02AQ48773126-B1EDE166-6806-405A-BD10-7138B7C083C1Q48948441-40CA2EC3-6CDE-422B-8A37-13296EDE3B71Q50861362-40D95C61-3A8C-4B02-B236-0850BB18BD4CQ54229364-BD40AF5C-7682-4E4E-A784-D5DDC7FA4FDDQ57655306-4E3A87B5-80C1-41F2-93C2-461DCB6E58B0Q57655339-EE518DB5-DD00-426A-A976-C816CB053A52Q57911720-55CC1657-DB3A-47E1-A4C6-EC3DD5245821
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Martina Absinta
@ast
Martina Absinta
@en
Martina Absinta
@es
Martina Absinta
@nl
type
label
Martina Absinta
@ast
Martina Absinta
@en
Martina Absinta
@es
Martina Absinta
@nl
prefLabel
Martina Absinta
@ast
Martina Absinta
@en
Martina Absinta
@es
Martina Absinta
@nl
P106
P1153
18436249500
P21
P31
P496
0000-0003-0276-383X